Search Results | Blood | American Society of Hematology

1-20 of 64

2 3 4

Sort by

Sort Order Select

Journal Articles

Single-cell multiomics reveals increased plasticity, resistant populations and stem-cell-like blasts in KMT2A -rearranged leukemia

Blood blood.2021013442.

DOI: https://doi.org/10.1182/blood.2021013442

Published: 2021

Includes: Supplemental data

Journal Articles

Single-Cell Multiomics Reveals Increased Plasticity, Resistant Populations and Stem-Cell-like Blasts in KMT2A-Rearranged Leukemia

Blood (2021) 138 (Supplement 1): 2203.

DOI: https://doi.org/10.1182/blood-2021-146102

Published: 2021

Journal Articles

Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib By Increasing TSP-1-Dependent TGF-β1 Activation in Bone Marrow

Chao Zhang, Xiaoxuan Xu, Timothy Trotter, Amjad Javed, Joanne E. Murphy-Ullrich, Juan Li, Yang Yang

Blood (2021) 138 (Supplement 1): 1575.

DOI: https://doi.org/10.1182/blood-2021-149310

Published: 2021

Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Blood (2019) 134 (Supplement_1): 5592.

DOI: https://doi.org/10.1182/blood-2019-130040

Published: 2019

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Wenrui Yang, MD, Xin Zhao, MD PhD, Guangxin Peng, MD, Li Zhang, MD, Liping Jing, MD, Kang Zhou, MD, Yang Li, MD, Lei Ye, MD, Yuan Li, MD, Jianping Li, MD, Huihui Fan, MD, Lin Song, MD, Yang Yang, MD, Youzhen Xiong, MD, Fengkui Zhang, MD, Jianxiang Wang, MD

Blood (2019) 134 (Supplement_1): 5016.

DOI: https://doi.org/10.1182/blood-2019-125620

Published: 2019

Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Blood (2019) 134 (Supplement_1): 3181.

DOI: https://doi.org/10.1182/blood-2019-128614

Published: 2019

Journal Articles

CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX–knockout mice

Lili Wang, Yang Yang, Camilo Ayala Breton, John White, Jia Zhang, Yan Che, Alexei Saveliev, Deirdre McMenamin, Zhenning He, Caitlin Latshaw, Mingyao Li, James M. Wilson

Blood (2019) 133 (26): 2745–2752.

DOI: https://doi.org/10.1182/blood.2019000790

Published: 2019

Includes: Supplemental data

Journal Articles

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

Yang Yang, Sorab Gupta, MD, Rashmika Potdar, MBBS, Mark S Morginstin, DO, Gabor Varadi, MD

Blood (2018) 132 (Supplement 1): 5644.

DOI: https://doi.org/10.1182/blood-2018-99-117720

Published: 2018

Journal Articles

Runx2 Deficiency in Committed Osteoblasts Promotes Myeloma Cell Homing to and Progression in New Bone Sites

Xiaoxuan Xu, Juan Li, MD, Timothy Trotter, Pramod Gowda, Xiaoxiao Hao, Jacob Calahan, Racquel Innis-Shelton, MD, Amjad Javed, Yang Yang, MD

Blood (2017) 130 (Supplement 1): 126.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.126.126

Published: 2017

Journal Articles

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

Jingsong He, MD, Qingxiao Chen, MS, Yang Yang, MD, Yi Li, MD, Li Yang, MD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 5392.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5392.5392

Published: 2017

Journal Articles

Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow

Xiaoxiao Hao, Ru Feng, MD, Timothy Trotter, Pramod Gowda, Mary Fok, Xiaoxuan Xu, Denise Peker, MD, Amjad Javed, Yang Yang, MD

Blood (2017) 130 (Supplement 1): 125.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.125.125

Published: 2017

Journal Articles

EZH2 Upregulation Is Associated with Unfavorable Prognosis in Diffuse Large B-Cell Lymphoma through Potential RUNX3 Downregulation

Denise Peker, MD, Samara Roman-Holba, Yuri Kwon, Jennifer Gordetsky, Amitkumar Mehta, MD, Andres Forero, Luciano J. Costa, MD PhD, Vishnu Reddy, MD, Yang Yang, Balabhadrapatruni VSK Chakravarthi, Sooryanarayana Varambally, PhD

Blood (2016) 128 (22): 5301.

DOI: https://doi.org/10.1182/blood.V128.22.5301.5301

Published: 2016

Journal Articles

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Xuanru Lin, M.MD, Qingxiao Chen, M.MD, Haimeng Yan, Xi Huang, M.MD, Yi Li, PhD, Li Yang, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 2086.

DOI: https://doi.org/10.1182/blood.V128.22.2086.2086

Published: 2016

Journal Articles

Crispr/Cas9-Mediated In Vivo Gene Targeting Corrects Haemostasis in Newborn and Adult FIX-KO Mice

Lili Wang, PhD, Yang Yang, PhD, John White, McMenamin Deirdre, Peter Bell, PhD, James M Wilson, MD PhD

Blood (2016) 128 (22): 1174.

DOI: https://doi.org/10.1182/blood.V128.22.1174.1174

Published: 2016

Journal Articles

Limb-Bud and Heart (LBH), Target of Mir-191, Is a Novel Positive Regulator of Erythroid Differentiation

Wentian Wang, Yang Yang, Yongjuan Duan, Huijuan Zhao, Xiao Hu, PhD

Blood (2016) 128 (22): 1199.

DOI: https://doi.org/10.1182/blood.V128.22.1199.1199

Published: 2016

Journal Articles

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

Qingxiao Chen, M.MD, Jingsong He, Xing Guo, M.MD, Jing Chen, M.MD, Xuanru Lin, M.MD, Xi Huang, M.MD, Haimeng Yan, Li Yang, PhD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5085.

DOI: https://doi.org/10.1182/blood.V128.22.5085.5085

Published: 2016

Journal Articles

Osteocyte Apoptosis Attracts Myeloma Cells to Bone and Supports Progression through Regulation of the Bone Marrow Microenvironment

Timothy N. Trotter, Mary Fok, Justin T. Gibson, Deniz Peker, MD, Amjad Javed, MSc, PhD, Yang Yang, MD PhD

Blood (2016) 128 (22): 484.

DOI: https://doi.org/10.1182/blood.V128.22.484.484

Published: 2016

Journal Articles

Set7 Is Highly Expressed in B-Lineage Acute Lymphoblastic Leukemia Cells and Overexpression of Set7 Exhibits Antileukemia Effect

Xiao-Tong Ma, PhD, Ya-Kun Mou, MD, Yang-Yang Zhao, PhD, Nan Wang, PhD, Xiao-Yan Liu, Jing Yin, Yan-Ping Ma, Dan Guo, PhD

Blood (2016) 128 (22): 5088.

DOI: https://doi.org/10.1182/blood.V128.22.5088.5088

Published: 2016

Journal Articles

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Fuming Zi, PhD, Jingsong He, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5703.

DOI: https://doi.org/10.1182/blood.V128.22.5703.5703

Published: 2016

Journal Articles

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Jingsong He, Xi Huang, M.MD, Haimeng Yan, Yi Li, PhD, Li Yang, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 4429.

DOI: https://doi.org/10.1182/blood.V128.22.4429.4429

Published: 2016

2 3 4

NARROW

Single-cell multiomics reveals increased plasticity, resistant populations and stem-cell-like blasts in KMT2A -rearranged leukemia

Single-Cell Multiomics Reveals Increased Plasticity, Resistant Populations and Stem-Cell-like Blasts in KMT2A-Rearranged Leukemia

Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib By Increasing TSP-1-Dependent TGF-β1 Activation in Bone Marrow

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX–knockout mice

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

Runx2 Deficiency in Committed Osteoblasts Promotes Myeloma Cell Homing to and Progression in New Bone Sites

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow

EZH2 Upregulation Is Associated with Unfavorable Prognosis in Diffuse Large B-Cell Lymphoma through Potential RUNX3 Downregulation

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Crispr/Cas9-Mediated In Vivo Gene Targeting Corrects Haemostasis in Newborn and Adult FIX-KO Mice

Limb-Bud and Heart (LBH), Target of Mir-191, Is a Novel Positive Regulator of Erythroid Differentiation

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

Osteocyte Apoptosis Attracts Myeloma Cells to Bone and Supports Progression through Regulation of the Bone Marrow Microenvironment

Set7 Is Highly Expressed in B-Lineage Acute Lymphoblastic Leukemia Cells and Overexpression of Set7 Exhibits Antileukemia Effect

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only